Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and animals and cosmeceutical and nutraceutical industries. The company’s portfolio include natural active ingredients comprising oat avenanthramides, oat oil, oat peptides, oat beta glucan, and lupin peptides; and veterinary products including oat shampoo, ear cleanser and dermal complex/conditioner. The company along with its subsidiaries operates mainly in the US, Germany, China, Canada and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada. Ceapro Inc (CZO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals... Research Beam Model: Research Beam Product ID: 1915865 250 USD New
Ceapro Inc (CZO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Ceapro Inc (CZO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 34
  • Publisher : GlobalData
 
 
 
Summary

Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and animals and cosmeceutical and nutraceutical industries. The company’s portfolio include natural active ingredients comprising oat avenanthramides, oat oil, oat peptides, oat beta glucan, and lupin peptides; and veterinary products including oat shampoo, ear cleanser and dermal complex/conditioner. The company along with its subsidiaries operates mainly in the US, Germany, China, Canada and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.

Ceapro Inc (CZO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ceapro Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ceapro Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ceapro Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Ceapro Expands Licensing Agreement with University of Alberta 10
Ceapro Enters into Licensing Agreement with University of Alberta 10
Symrise Enters Into Licensing Agreement With Ceapro 11
Equity Offering 12
Ceapro Raises USD3.3 Million in Second and Final Tranche of Private Placement of Units 12
Ceapro Raises USD4.4 Million in First Tranche of Brokered Private Placement of Units 13
Debt Offering 15
Ceapro Raises USD0.24 Million in Second Tranche of Private Placement of Debentures Due 2016 15
Ceapro Inc - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 17, 2017: Ceapro Reports 2017 First Quarter Development Highlights and Financial Results 20
Apr 06, 2017: Ceapro Reports 2016 Financial Results and Provides Corporate Update 22
Nov 23, 2016: Ceapro Reports Third Quarter 2016 Financial and Operational Results 24
Aug 24, 2016: Ceapro Reports Second Quarter 2016 Financial and Operational Results 25
May 18, 2016: Ceapro Reports 2016 First Quarter Financial Results and Provides Corporate Update 26
Apr 14, 2016: Ceapro Inc. Reports 2015 Financial Results, Best Financial Year in Company's History 28
Legal and Regulatory 29
Feb 03, 2016: Ceapro Issued U.S. Patent for Enabling Pressurized Gas Expanded Technology 29
Government and Public Interest 31
Sep 21, 2016: Ceapro Awarded Research Grant from German-Canadian Centre for Innovation and Research 31
Other Significant Developments 32
Apr 18, 2016: Ceapro Inc. Provides 2015 Business Highlights and 2016 Business Outlook 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
Ceapro Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ceapro Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ceapro Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ceapro Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ceapro Expands Licensing Agreement with University of Alberta 10
Ceapro Enters into Licensing Agreement with University of Alberta 10
Symrise Enters Into Licensing Agreement With Ceapro 11
Ceapro Raises USD3.3 Million in Second and Final Tranche of Private Placement of Units 12
Ceapro Raises USD4.4 Million in First Tranche of Brokered Private Placement of Units 13
Ceapro Raises USD0.24 Million in Second Tranche of Private Placement of Debentures Due 2016 15
Ceapro Inc, Key Competitors 17
Ceapro Inc, Key Employees 18
Ceapro Inc, Subsidiaries 19List of Figures
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter